Epsilogen
Marianne Uteng - Director
Oncology
London, UK
Epsilogen is a biotechnology company developing immunoglobulin E (IgE) antibodies to treat cancer.
It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.